Barry D Quart is of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 9,373 shares of KNSA, which is worth approximately $215,672. The most recent transaction as insider was on Jun 06, 2024, when has been sold 4,373 shares (Class A Common Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.37K
0% 3M change
87.46% 12M change
Total Value Held $215,672

Barry D Quart Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Exercise of conversion of derivative security
-
4,373 Added 31.81%
9,373 Class A Common Share
Jun 29 2023
BUY
Exercise of conversion of derivative security
-
5,000 Added 50.0%
5,000 Class A Common Share
Nov 29 2022
SELL
Open market or private sale
$354,637 $16.15 p/Share
21,959 Reduced 100.0%
0 Class A Common Share
Nov 29 2022
BUY
Exercise of conversion of derivative security
$34,914 $1.59 p/Share
21,959 Added 50.0%
21,959 Class A Common Share

Also insider at

HRTX
HERON THERAPEUTICS, INC. Healthcare
BDQ

Barry D Quart

San Diego, CA

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA